{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T07:52:24Z","timestamp":1776153144415,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82560520"],"award-info":[{"award-number":["82560520"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10142-026-01868-2","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T07:02:01Z","timestamp":1776150121000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integration of clinical and cellular lipidomics identifies a serum metabolite signature predictive of oxaliplatin resistance in colorectal cancer"],"prefix":"10.1007","volume":"26","author":[{"given":"Xue-fei","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-ye","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-wei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-tang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-fang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bang-li","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"10","key":"1868_CR1","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1007\/s11427-024-2657-y","volume":"67","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zheng Z (2024) Understanding the global cancer statistics 2022: growing cancer burden. Sci China Life Sci 67(10):2274\u20132276","journal-title":"Sci China Life Sci"},{"issue":"1","key":"1868_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s43556-025-00361-9","volume":"6","author":"Y Jin","year":"2025","unstructured":"Jin Y, He X, Wu Y (2025) Gastrointestinal cancer: molecular pathogenesis and targeted therapy. Mol Biomed 6(1):136","journal-title":"Mol Biomed"},{"issue":"19","key":"1868_CR3","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.3390\/cancers14194812","volume":"14","author":"GM Ramzy","year":"2022","unstructured":"Ramzy GM, Boschung L, Koessler T, Delucinge-Vivier C, Docquier M, McKee TA, Rubbia-Brandt L, Nowak-Sliwinska P (2022) FOLFOXIRI Resistance Induction and Characterization in Human Colorectal Cancer Cells. Cancers (Basel) 14(19):4812","journal-title":"Cancers (Basel)"},{"key":"1868_CR4","doi-asserted-by":"publisher","first-page":"1571731","DOI":"10.3389\/fimmu.2025.1571731","volume":"16","author":"JM Oh","year":"2025","unstructured":"Oh JM, Kim S, Tsung C, Kent E, Jain A, Ruff SM, Zhang H (2025) Comprehensive review of the resistance mechanisms of colorectal cancer classified by therapy type. Front Immunol 16:1571731","journal-title":"Front Immunol"},{"key":"1868_CR5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1146\/annurev-pathmechdis-031521-041113","volume":"18","author":"JC Sedlak","year":"2023","unstructured":"Sedlak JC, Yilmaz OH, Roper J (2023) Metabolism and Colorectal Cancer. Annu Rev Pathol 18:467\u2013492","journal-title":"Annu Rev Pathol"},{"key":"1868_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.semcdb.2019.05.018","volume":"98","author":"S La Vecchia","year":"2020","unstructured":"La Vecchia S, Sebastian C (2020) Metabolic pathways regulating colorectal cancer initiation and progression. Semin Cell Dev Biol 98:63\u201370","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"1868_CR7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12672-025-04349-3","volume":"17","author":"P Lu","year":"2025","unstructured":"Lu P, Wang Z (2025) Lipid metabolism in colorectal cancer: dual roles and statin therapy. Discov Oncol 17(1):164","journal-title":"Discov Oncol"},{"issue":"11","key":"1868_CR8","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.trecan.2025.08.005","volume":"11","author":"G Medina Evora","year":"2025","unstructured":"Medina Evora G, Brauer M, Letellier E (2025) Host and microbiome lipid metabolism in colorectal cancer development and therapy. Trends Cancer 11(11):1041\u20131057","journal-title":"Trends Cancer"},{"issue":"13","key":"1868_CR9","doi-asserted-by":"publisher","first-page":"10867","DOI":"10.3390\/ijms241310867","volume":"24","author":"AR Markowski","year":"2023","unstructured":"Markowski AR, Blachnio-Zabielska AU, Pogodzinska K, Markowska AJ, Zabielski P (2023) Diverse Sphingolipid Profiles in Rectal and Colon Cancer. Int J Mol Sci 24(13):10867","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1868_CR10","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.21873\/anticanres.15819","volume":"42","author":"T Hiraide","year":"2022","unstructured":"Hiraide T, Morita Y, Horikawa M, Sugiyama E, Sato T, Kahyo T, Furuhashi S, Takeda M, Kikuchi H, Hiramatsu Y et al (2022) Saturated Fatty Acids in Cell Membrane Lipids Induce Resistance to 5-Fluorouracil in Colorectal Cancer Cells. Anticancer Res 42(7):3313\u20133324","journal-title":"Anticancer Res"},{"issue":"6","key":"1868_CR11","doi-asserted-by":"publisher","first-page":"3178","DOI":"10.3390\/ijms25063178","volume":"25","author":"PD Leiphrakpam","year":"2024","unstructured":"Leiphrakpam PD, Are C (2024) PI3K\/Akt\/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment. Int J Mol Sci 25(6):3178","journal-title":"Int J Mol Sci"},{"issue":"9\u201310","key":"1868_CR12","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1007\/s10495-025-02143-8","volume":"30","author":"D Hu","year":"2025","unstructured":"Hu D, Liu H, Guo Y, Zhang H, Qiu M, Yang Z, Hao J, Jiang Z, Gao M, Zhang X et al (2025) Microplastics promote chemoresistance by mediating lipid metabolism and suppressing pyroptosis in colorectal cancer. Apoptosis 30(9\u201310):2287\u20132300","journal-title":"Apoptosis"},{"issue":"1","key":"1868_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40169-018-0182-9","volume":"7","author":"TA Lydic","year":"2018","unstructured":"Lydic TA, Goo YH (2018) Lipidomics unveils the complexity of the lipidome in metabolic diseases. Clin Transl Med 7(1):4","journal-title":"Clin Transl Med"},{"issue":"1","key":"1868_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/metabo14010008","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu X, Weigert C (2023) State-of-the-Art Metabolomics and Lipidomics in Life Sciences: Methods and Applications. Metabolites 14(1):8","journal-title":"Metabolites"},{"issue":"1","key":"1868_CR15","doi-asserted-by":"publisher","first-page":"13671","DOI":"10.1038\/s41598-025-97463-9","volume":"15","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Ye L, Qin Y, Qiu C, Sun Q, Fan T, Chen Y, Jiang Y (2025) Serum metabolomics to identify molecular subtypes and predict XELOX efficacy in colorectal cancer. Sci Rep 15(1):13671","journal-title":"Sci Rep"},{"issue":"1","key":"1868_CR16","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12672-025-04183-7","volume":"17","author":"M Li","year":"2025","unstructured":"Li M, Yu C, Li Z, Xiong L, Wang J, Shang X, Sun H, Chang Y, Du X, Zheng R (2025) Comparative metabolomics reveals specific metabolic signatures in colorectal cancer cell line models. Discov Oncol 17(1):26","journal-title":"Discov Oncol"},{"key":"1868_CR17","doi-asserted-by":"publisher","first-page":"1517446","DOI":"10.3389\/fphar.2025.1517446","volume":"16","author":"H Xu","year":"2025","unstructured":"Xu H, Li M, Yao H, Chen G, Chen J, Hou X, Yang H, Yu C, Lin Z, Zhu J et al (2025) Multi-tissue metabolomics analysis reveals susceptible factors for chemotherapy-induced hepatotoxicity in colorectal cancer patients. Front Pharmacol 16:1517446","journal-title":"Front Pharmacol"},{"issue":"2","key":"1868_CR18","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228\u2013247","journal-title":"Eur J Cancer"},{"issue":"12","key":"1868_CR19","doi-asserted-by":"publisher","first-page":"114150","DOI":"10.1016\/j.isci.2025.114150","volume":"28","author":"F Cheng","year":"2025","unstructured":"Cheng F, Huang L, Peng Y, Luo L, Zhong L, Ju Y, Lu Y, Ouyang M (2025) Regulatory role of phosphatidylcholine metabolic reprogramming in colorectal cancer progression and neutrophil interactions. iScience 28(12):114150","journal-title":"iScience"},{"issue":"9","key":"1868_CR20","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s42255-020-0250-5","volume":"2","author":"JM Orozco","year":"2020","unstructured":"Orozco JM, Krawczyk PA, Scaria SM, Cangelosi AL, Chan SH, Kunchok T, Lewis CA, Sabatini DM (2020) Dihydroxyacetone phosphate signals glucose availability to mTORC1. Nat Metab 2(9):893\u2013901","journal-title":"Nat Metab"},{"key":"1868_CR21","doi-asserted-by":"publisher","first-page":"1623295","DOI":"10.3389\/fnut.2025.1623295","volume":"12","author":"X Shu","year":"2025","unstructured":"Shu X, Lin J, Yao L, Liu S, Chen Q, Wang H, Wang L (2025) Dietary Omega-3 intake may slow prostate cancer progression and reduce mortality risk: evidence from prostate, lung, colorectal, and ovarian cancer screening trial. Front Nutr 12:1623295","journal-title":"Front Nutr"},{"issue":"7","key":"1868_CR22","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3390\/nu16071040","volume":"16","author":"YM Yu","year":"2024","unstructured":"Yu YM, Li GF, Ren YL, Xu XY, Xu ZH, Geng Y, Mao Y (2024) A Free Amino Acid Diet Alleviates Colorectal Tumorigenesis through Modulating Gut Microbiota and Metabolites. Nutrients 16(7):1040","journal-title":"Nutrients"},{"issue":"9","key":"1868_CR23","doi-asserted-by":"publisher","first-page":"97008","DOI":"10.1289\/EHP4713","volume":"127","author":"DK Barupal","year":"2019","unstructured":"Barupal DK, Fiehn O (2019) Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect 127(9):97008","journal-title":"Environ Health Perspect"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01868-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-026-01868-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-026-01868-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T07:02:02Z","timestamp":1776150122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-026-01868-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1868"],"URL":"https:\/\/doi.org\/10.1007\/s10142-026-01868-2","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approval by the Ethics Committee of Guangxi Medical University Cancer Hospital. All the procedures were carried out in accordance with institutional guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}